KMDA

NASDAQ · Biotechnology

Kamada Ltd

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks Best Dividend Stocks Highest Dividend Yield

$8.41

+0.15 (+1.82%)

As of May 9, 1:48 AM ET ·

Financial Highlights (FY 2026)

Revenue

181.39M

Net Income

20.30M

Gross Margin

42.3%

Profit Margin

11.2%

Rev Growth

+11.8%

D/E Ratio

0.04

Revenue & Net Income

Margin Trends

	FY 2026	FY 2025	FY 2024	FY 2023
Gross Margin	42.3%	42.3%	32.9%	32.9%
Operating Margin	14.5%	13.1%	-3.3%	-2.9%
Profit Margin	11.2%	10.6%	-3.0%	-3.4%

Income Statement

	FY 2026	FY 2025	FY 2024	FY 2023
Revenue	181.39M	162.32M	67.17M	56.23M
Gross Profit	76.80M	68.73M	22.13M	18.52M
Operating Income	26.37M	21.24M	-2,240,257	-1,617,847
Net Income	20.30M	16.35M	-1,989,318	-1,893,818
Gross Margin	42.3%	42.3%	32.9%	32.9%
Operating Margin	14.5%	13.1%	-3.3%	-2.9%
Profit Margin	11.2%	10.6%	-3.0%	-3.4%
Rev Growth	+11.8%	+11.8%	+14.3%	-2.8%

Balance Sheet

	FY 2026	FY 2025	FY 2024	FY 2023
Total Debt	10.17M	10.17M	36.09M	37.79M
Total Equity	236.44M	236.44M	407.35M	369.18M
D/E Ratio	0.04	0.04	0.09	0.10

Cash Flow

	FY 2026	FY 2025	FY 2024	FY 2023
EBITDA	25.76M	21.90M	-2,803,887	-1,985,807
Free Cash Flow	—	—	-2,727,774	-1,789,276